ACTIDIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Actidil, and what generic alternatives are available?
Actidil is a drug marketed by Glaxosmithkline and is included in two NDAs.
The generic ingredient in ACTIDIL is triprolidine hydrochloride. There are thirteen drug master file entries for this compound. Additional details are available on the triprolidine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACTIDIL?
- What are the global sales for ACTIDIL?
- What is Average Wholesale Price for ACTIDIL?
Summary for ACTIDIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 33 |
| Patent Applications: | 5,256 |
| DailyMed Link: | ACTIDIL at DailyMed |
US Patents and Regulatory Information for ACTIDIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | ACTIDIL | triprolidine hydrochloride | SYRUP;ORAL | 011496-002 | Jul 1, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Glaxosmithkline | ACTIDIL | triprolidine hydrochloride | TABLET;ORAL | 011110-002 | Jul 1, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
